GGrantIndex
Sort

51,593 grants matching hepatitis

Increasing Uptake of Evidence Based Screening Services though a CHW-led multi-modality program: The South Florida Center for Reducing Health Disparities

$487,186
Olveen Carrasquillo · University Of Miami School Of Medicine · U01 · FY2017 · MD

CETP and Sex-Differences in Metabolic and Cardiovascular Disease

$487,084
John Micheal Stafford · Vanderbilt University Medical Center · R01 · FY2020 · HL

Targeting Scap to Lower ApoB-Containing Lipoproteins (ApoBCL) Production

$487,080
Arun Radhakrishnan · Ut Southwestern Medical Center · P01 · FY2024 · HL

Targeting Scap to Lower ApoB-Containing Lipoproteins (ApoBCL) Production

$487,080
Arun Radhakrishnan · Ut Southwestern Medical Center · P01 · FY2025 · HL

Increasing Hep B screening among Korean church attendees

$487,036
Roshan Bastani · University Of California At Davis · P01 · FY2009 · CA

Etiology and Treatment of Biliary Atresia and Idiopathic Neonatal Hepatitis

$486,984
Ronald J Sokol · University Of Colorado Denver · U01 · FY2008 · DK

QUANTITATIVE STUDIES OF METABOLIC ORGAN DYNAMICS

$486,956
University Of Southern California · R01 · FY2004 · DK

Tagged binding agents as improved anti-toxin therapeutics

$486,911
Charles Bix Shoemaker · Harvard Medical School · U54 · FY2012 · AI

Metabolism of islets of langerhans and hormone release

$486,906
Franz M Matschinsky · University Of Pennsylvania · R01 · FY2009 · DK

Novel therapeutic approaches to treating chronic hepatitis B virus infection

$486,852
Lishan Su · Univ Of North Carolina Chapel Hill · R01 · FY2016 · DK

Novel therapeutic approaches to treating chronic hepatitis B virus infection

$486,852
Lishan Su · Univ Of North Carolina Chapel Hill · R01 · FY2014 · DK

Acute Hepatitis C Infection in Young Injectors

$486,800
Kimberly Page · University Of California, San Francisco · R01 · FY2007 · DA

Crossing Borders: HIV and Substance use at the Gateway to North America

$486,772
Kimberly C Brouwer · University Of California, San Diego · R01 · FY2010 · DA

Ontogeny of drug transport

$486,760
Bhagwat Prasad · Cincinnati Childrens Hosp Med Ctr · R01 · FY2025 · HD

DAT-Emulating target trials with big data to strengthen the evidence base for the clinical management of opioid use disorder

$486,752
Bohdan Nosyk · Simon Fraser University · R01 · FY2023 · DA

Effect of sphingomyelin biosynthesis on atherosclerosis

$486,746
Xian-Cheng Jiang · Suny Downstate Medical Center · R01 · FY2023 · HL

Association of Nutritional and Biocfiemical Predictors of Body Fat Amount and Di

$486,721
Unhee Lim · University Of Hawaii At Manoa · P01 · FY2013 · CA

Immunogenicity of Synthetic Peptide Malaria Vaccines

$486,721
Elizabeth H Nardin · New York University School Of Medicine · R01 · FY2006 · AI

Postprandial Vitamin A

$486,711
William S Blaner · Columbia University Health Sciences · R01 · FY2023 · DK

Functional Anatomy of Neuroimmune Interactions

$486,695
Paul E. Sawchenko · Salk Institute For Biological Studies · R01 · FY2012 · NS

Functional Anatomy of Neuroimmune Interactions

$486,695
Paul E. Sawchenko · Salk Institute For Biological Studies · R01 · FY2011 · NS

Molecular Mechanisms of Chemoprevention: NRF2 Signaling

$486,646
Thomas W Kensler · University Of Pittsburgh At Pittsburgh · R01 · FY2012 · CA

The Role of Portal Fibroblasts in Cholestatic Liver Fibrosis

$486,640
Tatiana Kisseleva · University Of California, San Diego · R01 · FY2022 · DK

The Role of Portal Fibroblasts in Cholestatic Liver Fibrosis

$486,640
Tatiana Kisseleva · University Of California, San Diego · R01 · FY2023 · DK

The Role of Portal Fibroblasts in Cholestatic Liver Fibrosis

$486,640
Tatiana Kisseleva · University Of California, San Diego · R01 · FY2021 · DK